Mireya Fuentes
About
In The Last Decade
Mireya Fuentes
22 papers receiving 475 citations
Peers
Comparison fields: 5 of 74
- Physiology 233
- Pharmacology 154
- Otorhinolaryngology 136
- Immunology and Allergy 122
- Pulmonary and Respiratory Medicine 90
Countries citing papers authored by Mireya Fuentes
This map shows the geographic impact of Mireya Fuentes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mireya Fuentes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mireya Fuentes more than expected).
Fields of papers citing papers by Mireya Fuentes
This network shows the impact of papers produced by Mireya Fuentes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mireya Fuentes. The network helps show where Mireya Fuentes may publish in the future.
Co-authorship network of co-authors of Mireya Fuentes
This figure shows the co-authorship network connecting the top 25 collaborators of Mireya Fuentes. A scholar is included among the top collaborators of Mireya Fuentes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mireya Fuentes. Mireya Fuentes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 23 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 15 | |
| 9 | 15 | |
| 10 | 11 | |
| 11 | 15 | |
| 12 | 27 | |
| 13 | 14 | |
| 14 | 18 | |
| 15 | Montelukast reduces eosinophilic inflammation by inhibiting both epithelial cell cytokine secretion (GM-CSF, IL-6, IL-8) and eosinophil survival. | 31 |
| 16 | 13 | |
| 17 | 26 | |
| 18 | 34 | |
| 19 | 188 | |
| 20 | 16 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.